PT - JOURNAL ARTICLE AU - Rachel M. Burke AU - Sharon Balter AU - Emily Barnes AU - Vaughn Barry AU - Karri Bartlett AU - Karlyn D. Beer AU - Isaac Benowitz AU - Holly M. Biggs AU - Hollianne Bruce AU - Jonathan Bryant-Genevier AU - Jordan Cates AU - Kevin Chatham-Stephens AU - Nora Chea AU - Howard Chiou AU - Demian Christiansen AU - Victoria Chu AU - Shauna Clark AU - Sara Cody AU - Max Cohen AU - Erin E. Conners AU - Vishal Dasari AU - Patrick Dawson AU - Traci DeSalvo AU - Matthew Donahue AU - Alissa Dratch AU - Lindsey Duca AU - Jeffrey Duchin AU - Jonathan W. Dyal AU - Leora R. Feldstein AU - Marty Fenstersheib AU - Marc Fischer AU - Rebecca Fisher AU - Chelsea Foo AU - Brandi Freeman-Ponder AU - Alicia M. Fry AU - Jessica Gant AU - Romesh Gautom AU - Isaac Ghinai AU - Prabhu Gounder AU - Cheri T. Grigg AU - Jeffrey Gunzenhauser AU - Aron J. Hall AU - George S. Han AU - Thomas Haupt AU - Michelle Holshue AU - Jennifer Hunter AU - Mireille B. Ibrahim AU - Max W. Jacobs AU - M. Claire Jarashow AU - Kiran Joshi AU - Talar Kamali AU - Vance Kawakami AU - Moon Kim AU - Hannah Kirking AU - Amanda Kita-Yarbro AU - Rachel Klos AU - Miwako Kobayashi AU - Anna Kocharian AU - Misty Lang AU - Jennifer Layden AU - Eva Leidman AU - Scott Lindquist AU - Stephen Lindstrom AU - Ruth Link-Gelles AU - Mariel Marlow AU - Claire P. Mattison AU - Nancy McClung AU - Tristan D. McPherson AU - Lynn Mello AU - Claire M. Midgley AU - Shannon Novosad AU - Megan T. Patel AU - Kristen Pettrone AU - Satish K. Pillai AU - Ian W. Pray AU - Heather E. Reese AU - Heather Rhodes AU - Susan Robinson AU - Melissa Rolfes AU - Janell Routh AU - Rachel Rubin AU - Sarah L. Rudman AU - Denny Russell AU - Sarah Scott AU - Varun Shetty AU - Sarah E. Smith-Jeffcoat AU - Elizabeth A. Soda AU - Chris Spitters AU - Bryan Stierman AU - Rebecca Sunenshine AU - Dawn Terashita AU - Elizabeth Traub AU - Grace E. Vahey AU - Jennifer R. Verani AU - Megan Wallace AU - Matthew Westercamp AU - Jonathan Wortham AU - Amy Xie AU - Anna Yousaf AU - Matthew Zahn TI - Enhanced Contact Investigations for Nine Early Travel-Related Cases of SARS-CoV-2 in the United States AID - 10.1101/2020.04.27.20081901 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.27.20081901 4099 - http://medrxiv.org/content/early/2020/05/03/2020.04.27.20081901.short 4100 - http://medrxiv.org/content/early/2020/05/03/2020.04.27.20081901.full AB - Background Coronavirus disease 2019 (COVID-19), the respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China and has since become pandemic. As part of initial response activities in the United States, enhanced contact investigations were conducted to enable early identification and isolation of additional cases and to learn more about risk factors for transmission.Methods Close contacts of nine early travel-related cases in the United States were identified. Close contacts meeting criteria for active monitoring were followed, and selected individuals were targeted for collection of additional exposure details and respiratory samples. Respiratory samples were tested for SARS-CoV-2 by real-time reverse transcription polymerase chain reaction (RT-PCR) at the Centers for Disease Control and Prevention.Results There were 404 close contacts who underwent active monitoring in the response jurisdictions; 338 had at least basic exposure data, of whom 159 had ≥1 set of respiratory samples collected and tested. Across all known close contacts under monitoring, two additional cases were identified; both secondary cases were in spouses of travel-associated case patients. The secondary attack rate among household members, all of whom had ≥1 respiratory sample tested, was 13% (95% CI: 4 – 38%).Conclusions The enhanced contact tracing investigations undertaken around nine early travel-related cases of COVID-19 in the United States identified two cases of secondary transmission, both spouses. Rapid detection and isolation of the travel-associated case patients, enabled by public awareness of COVID-19 among travelers from China, may have mitigated transmission risk among close contacts of these cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was sought or received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData may be available upon reasonable request.